Skip to content

Analgesic Properties of Oral Sucrose During Immunizations

Efficacy of Oral Sucrose and Maternal Contact During Routine Immunizations in Postnatal Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00446875
Enrollment
98
Registered
2007-03-13
Start date
2007-01-31
Completion date
2008-05-19
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Procedural Pain

Keywords

Pain, Procedural pain, Sucrose, Infant

Brief summary

The purpose of this study is to examine the analgesic properties of oral sucrose during routine immunizations. Hypothesis: Oral sucrose solution and maternal contact will significantly decrease the objective measures of acute pain during routine immunizations.

Detailed description

The purpose of this study is to examine the analgesic properties of oral sucrose during routine immunizations. Hypothesis: Oral sucrose solution and maternal contact will significantly decrease the objective measures of acute pain during routine immunizations. Acute pain during early life may alter infant pain responses, cognitive development and behavioral outcomes. Infants respond to immunizations with significant pain and distress. This study will examine the analgesic properties of oral sucrose and maternal holding in postnatal infants. Comparison: Administration of oral sucrose, sterile water and maternal contact 2 minutes before routine immunizations.

Interventions

OTHERAdministration of oral Sucrose

Participants received oral sucrose 2 minutes prior to the combind DTaP, IPV, and Hep B vaccine.

OTHERAdministration of oral Placebo

Participants received Placebo 2 minutes prior to the combind DTaP, IPV, and Hep B vaccine.

Sponsors

Milton S. Hershey Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double Blind (subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Months to 11 Months
Healthy volunteers
Yes

Inclusion criteria

1. Currently between 4 and 11 months of age; 2. Between 37 and 42 weeks' completed gestation at birth; 3. Birth weight greater than 2.5 kg; and 4. No evidence of acute or chronic disease

Exclusion criteria

1. Fed 30 minutes prior to immunization; 2. Received analgesic/sedative the day of the immunizations; 3. Parent wishes to feed the infant during the immunizations; 4. Infant is diagnosed with a major congenital disorder where the behavioral responses to painful stimuli may be altered; or 5. Language barriers preclude the process of obtaining parental consent.

Design outcomes

Primary

MeasureTime frameDescription
Behavioral pain responseBaseline, and then at 2 and 5 minutes post DTaP, IPV, and Hep B vaccineInfants will be evaluated based on the University of Wisconsin Children's Hospital Pain Scale to score an infant's pain. Possible scores range from 0 (no pain) to 5 (worst possible pain).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026